Vimta Labs Limited has signed a Business Transfer Agreement to sell its Clinical Diagnostics Business Division to Thyrocare Technologies for a total revenue of INR 30 Crores in FY 2024 and INR 7 Crores in Q1 FY 2025, aiming to enhance Thyrocares market share in South India.